Innovation in ePRO for Questionnaire Data Capture
AI Webinar Explorer now available for enhanced on-demand viewing
About this webinar
Clinical Ink announces the release of its most recent innovation in ePRO improving questionnaire design quality and efficiency. This release brings with it the next logical step in truly configurable ePRO delivery for both full library support and point and click scoring and coding. These latest innovations in ePRO from Clinical Ink will bring much needed efficiency and increased simplicity for delivering questionnaire scoring solutions in overall study data but also for study design in screening and randomization needs. Further, with the release of our revolutionary configurable ePRO library for Patient Reported Outcome Measures, Clinical Ink brings clinical trials one step closer to point and click ePRO implementation.
Join us for this webinar and find out how your studies can benefit from leveraging these disruptive innovations in your ePRO solutions.
Who should attend
- ePRO / ePRO Category / Data Managers
- Clinical Trial / Clinical Study Leads
- Therapeutic Strategy Leads
- Biometrics / Bio Stats Managers
- Clinical Operations Specialists
- Clinical Operations Directors / VPs
What you will learn
Join us for this webinar and find out how your studies can benefit from leveraging these disruptive innovations in questionnaire data capture in your ePRO solutions.
Featured Speakers
Kyle Hogan
Kyle Hogan is the eClinical Solutions Director with Clinical Ink. He is responsible for the strategic alignment of the company’s native mobile application for clinical trials, SureSource Engage. Kyle has delivered technical solutions for complex business challenges since the 1990s and has 10+ years of experience in clinical trials. He has managed numerous global ePRO trial deployments and developed a mobile patient training solution for eCOA. Kyle is an industry expert in realizing fully BYOD capable eCOA, patient engagement, and connected sensor solutions through mobile applications for use by patients in clinical trials.
Ryan Belmont, MBA
Ryan Belmont, MBA, is the Director of Product Management with Clinical Ink, and is responsible for the overall strategic roadmap of SureSource Engage. Ryan has been involved with mobile application design and build since the beginning of the smartphone boom, and has spent the past 5 years working to bring effective patient engagement and viable ePRO solutions to patients’ personal devices via the SureSource Engage app.
Partner for this event
Clinical Ink
Clinical Ink is a global clinical trial technology company that is transforming the clinical trial experience. Founded in 2007, the Company’s proven and future-built eSource platform, which includes solutions for EDC replacement, eCOA, ePRO and more, accelerates time to value while delivering scientific results that matter. With offices in Winston-Salem, NC, and Philadelphia, PA, Clinical Ink is advancing the business model responsible for bringing new treatments to market. Visit clinicalink.com.
Related webinars
More from Clinical Ink.
COAs in Early-Stage Alzheimer’s Trials: How scientific strategy, eCOA & rater training align to protect endpoint & data quality
Enhancing Cardiometabolic Trials with Configurable eCOA and Digital Health Technologies
From Signals to Strategy: The Next Chapter of Digital Biomarkers
BYOD or Bust: Are Clinical Trials Ready for the Device Revolution?
Optimizing Patient Adherence in Clinical Trials: The Science of Risk Identification and Personalized Digital Interventions
Innovation Labs: Accelerating Innovation at the Intersection of Pharmaceutical Research and Digital Health
Electronic Data Capture Redefined: Challenging the Norm with eSource Innovation
Solving unmet needs in GLP1 cardiometabolic clinical trials: novel approaches to digital data capture and patient retention
New Approaches to Adherence and Prevention of Dropouts: The Digital Era of Patient Engagement
Solving Data Collection Challenges in Lupus Trials with the Electronic Lupus Assessment Suite
Empowerment Model: An eCOA Subscription Model for Maximum Efficiency, Cost Savings, and Control
Bring Your Own Device: Why the Future of Clinical Trials Lies in Your Patients’ Hands